- Home
- RLAY vs SLSR Comparison
RLAY vs SLSR Comparison
Compare RLAY & SLSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- SLSR
- Stock Information
- Founded
- RLAY 2015
- SLSR 2018
- Country
- RLAY United States
- SLSR Switzerland
- Employees
- RLAY N/A
- SLSR N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- SLSR
- Sector
- RLAY Health Care
- SLSR
- Exchange
- RLAY Nasdaq
- SLSR NYSE
- Market Cap
- RLAY 490.3M
- SLSR 539.0M
- IPO Year
- RLAY 2020
- SLSR N/A
- Fundamental
- Price
- RLAY $3.18
- SLSR $4.44
- Analyst Decision
- RLAY Strong Buy
- SLSR Buy
- Analyst Count
- RLAY 11
- SLSR 2
- Target Price
- RLAY $18.40
- SLSR $11.00
- AVG Volume (30 Days)
- RLAY 1.5M
- SLSR 39.1K
- Earning Date
- RLAY 08-05-2025
- SLSR 08-08-2025
- Dividend Yield
- RLAY N/A
- SLSR N/A
- EPS Growth
- RLAY N/A
- SLSR N/A
- EPS
- RLAY N/A
- SLSR N/A
- Revenue
- RLAY $7,679,000.00
- SLSR N/A
- Revenue This Year
- RLAY $14.31
- SLSR N/A
- Revenue Next Year
- RLAY N/A
- SLSR N/A
- P/E Ratio
- RLAY N/A
- SLSR N/A
- Revenue Growth
- RLAY N/A
- SLSR N/A
- 52 Week Low
- RLAY $1.78
- SLSR $1.90
- 52 Week High
- RLAY $10.72
- SLSR $4.76
- Technical
- Relative Strength Index (RSI)
- RLAY 55.48
- SLSR 52.89
- Support Level
- RLAY $2.98
- SLSR $4.33
- Resistance Level
- RLAY $3.48
- SLSR $4.70
- Average True Range (ATR)
- RLAY 0.25
- SLSR 0.20
- MACD
- RLAY -0.00
- SLSR -0.02
- Stochastic Oscillator
- RLAY 58.45
- SLSR 37.40
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About SLSR SOLARIS RESOURCES INC
Solaris Resources Inc is advancing a portfolio of copper and gold assets in the Americas, which includes a high-grade resource with expansion and additional discovery potential at the Warintza copper and gold project in Ecuador; discovery potential on the grass-roots Tamarugo project in Chile and Capricho and Paco Orco projects in Peru, and the La Verde joint venture project.